ZEISS Medical Technology has showcased new surgical workflow innovations at the recent American Society of Cataract and Refractive Surgery (ASCRS) annual conference, which took place on May 6-8, 2023, in San Diego, CA. These products as part of the ZEISS Medical Ecosystem help enhance ophthalmic care within the cataract and corneal refractive workflows for improved diagnosis and treatment efficiency of surgical patients:
- The ATLAS™ 500 from ZEISS supports more efficient surgical diagnostics enhancing patient outcomes.
- The CT LUCIA® 621P Monofocal IOL from ZEISS received U.S. FDA approval, offering a unique ZEISS Optic to treat a wide range of cataract patients.
- With more than 7 million eyes treated with SMILE® worldwide, the ZEISS LVC portfolio helps create a high vision standard in laser vision correction.
- The VISULAS® yag laser from ZEISS delivers high-precision treatment for a high variety of IOL conditions.
“We are excited to offer these innovations to help maximize surgical workflow efficiency and performance, and further transform patient care in ophthalmology,” said Euan S. Thomson, PhD, President of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit for ZEISS Medical Technology. “ZEISS believes in a fully connected and integrated approach to eye care, and we continue to focus on the development of workflow solutions that will improve the quality of life for patients.”
Read the full press release from ZEISS.